Cyclacel Pharmaceuticals Reports First Quarter 2017 Financial Results BERKELEY HEIGHTS, N.J., May 11, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ("Cyclacel" or the "Company") a biopharmaceutical company developing oral...

Biodesix Presents Data From Three Studies at AACR Annual Meeting BOULDER, Colo., April 05, 2017 (GLOBE NEWSWIRE) -- Biodesix is presenting three studies that support the company’s multi-omic capabilities and provide insight into the biology of classifiers...

Cyclacel Presents Identification of Sensitive Target Indications and Synergistic Drug Combinations for Novel PLK1 Inhibitor CYC140 - Preclinical Data Presented at the AACR 2017 Meeting - BERKELEY HEIGHTS, N.J., April 04, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (Cyclacel or the...